Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
Clinical Trial to Slow the Progression of ADPKD
This study is not yet open for patient recruitment.
Sponsored by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
---|---|
Information provided by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Purpose
This study will determine whether certain blood pressure medications will slow cyst growth or keep kidneys functioning longer in patients with autosomal dominant polycystic kidney disease (ADPKD). The study will take place at several sites in the United States. The start date of the study has not yet been determined.
Condition | Treatment or Intervention |
---|---|
Kidney, Polycystic Kidney, Polycystic, Autosomal Dominant |
Drug: anti-hypertensive medications |
MedlinePlus related topics: Kidney Diseases
Study Type: Interventional
Study Design: Treatment, Active Control
Eligibility
Ages Eligible for Study: 15 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Location Information
More Information
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |